Cytomx Therapeutics Stock Forecast

Sell candidate since May 28, 2026 Loss -18.87%

The CytomX Therapeutics stock price gained 1.01% on the last trading day (Friday, 12th Jun 2026), rising from $2.98 to $3.01. During the last trading day the stock fluctuated 2.87% from a day low at $2.96 to a day high of $3.05. The price has fallen in 6 of the last 10 days and is down by -16.39% for this period. Volume fell on the last day by -222 thousand shares and in total, 2 million shares were bought and sold for approximately $6.17 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.85 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -27.90% during the next 3 months and, with a 90% probability hold a price between $2.05 and $3.52 at the end of this 3-month period.

CTMX Signals & Forecast

There are mixed signals in the stock today. The CytomX Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.67. On a fall, the stock will find some support from the short-term average at $3.00. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 3.44%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for CytomX Therapeutics stock

CytomX Therapeutics finds support from accumulated volume at $3.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0850 between high and low, or 2.87%. For the last week, the stock has had daily average volatility of 5.05%.

CytomX Therapeutics is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CTMX) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect CytomX Therapeutics to open at $3.01, and during the day (based on 14 day Average True Range), to move between $2.91 and $3.11, which gives a possible trading interval of +/-$0.199 (+/-6.83%) up or down from last closing price. If CytomX Therapeutics takes out the full calculated possible swing range there will be an estimated 6.83% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.00 (0.33%) than the resistance at $3.16 (4.98%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is CytomX Therapeutics stock A Buy?

CytomX Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.827 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $3.01 ( 0.166%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk